Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Pinar Bilir"'
Autor:
Olalekan O. Oluwole, Markqayne D. Ray, Richard M. Zur, Cheryl P. Ferrufino, Brett Doble, Anik R. Patel, S. Pinar Bilir
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionNovel therapies for 3L+ relapsed/refractory (r/r) follicular lymphoma (FL) have been approved recently by the US Food and Drug Administration including anti-CD19 CAR-T therapies such as axicabtagene ciloleucel (axi-cel) and CD20 × CD3 T-
Externí odkaz:
https://doaj.org/article/0bf9658a2eb640f7b7c7528ac49a045b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Diabetes Therapy. 13:1933-1945
For people with type 2 diabetes (T2D) on intensive insulin therapy, the use of flash continuous glucose monitoring ("flash monitoring") is associated with improved average glucose control and/or reduced hypoglycemic exposure. This study assessed the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::255d76484c93a3c1242fccbcb620f100
https://doi.org/10.1007/s13300-022-01325-w
https://doi.org/10.1007/s13300-022-01325-w
Autor:
Deborah M Anderson, Veena R Kumar, Diana L Arper, Eliza Kruger, S Pinar Bilir, Jason S Richardson
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224700 (2019)
BACKGROUND:Botulism is a rare, serious, and sometimes fatal paralytic illness caused by exposure to neurotoxins produced by Clostridium botulinum bacteria. Patients with documented or suspected exposure to botulinum toxin serotypes A-G can be treated
Externí odkaz:
https://doaj.org/article/eb05d6e12937453db2244f682429883c
Autor:
Olalekan O. Oluwole, Markqayne D. Ray, Katherine L. Rosettie, Graeme Ball, Jorge Jacob, Pinar Bilir, Anik R. Patel, Caron A. Jacobson
Publikováno v:
Blood. 140:10822-10824
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abbb3a7a98ad6c629886058b442ff898
https://doi.org/10.1182/blood-2022-163789
https://doi.org/10.1182/blood-2022-163789
Publikováno v:
The American Journal of Managed Care. 27:e269-e277
Objectives Using a US payer perspective, this study aimed to compare the lifetime cost-effectiveness of adding sodium-glucose cotransporter 2 (SGLT2) inhibitors vs switching to glucagon-like peptide 1 receptor agonists (GLP-1 RAs) among patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82b592013449bc9f7cbd5eb2eb93d033
https://doi.org/10.37765/ajmc.2021.88728
https://doi.org/10.37765/ajmc.2021.88728
Autor:
J. Munakata, Joanna Sickler, Mathilde Faller, James Karichu, Mindy M. Cheng, Eliza Kruger, S Pinar Bilir
Publikováno v:
The American Journal of Managed Care. 27:e157-e163
OBJECTIVES In the United States, approximately 12 million individuals seek medical care for pharyngitis each year, accounting for about 2% of ambulatory care visits. Although the gold standard for diagnosing group A streptococcus (GAS) is culture, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e74c14ec04d52c7be7151aa15ffcc81d
https://doi.org/10.37765/ajmc.2021.88638
https://doi.org/10.37765/ajmc.2021.88638
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions. 2:100942
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5687e1182e314cb50a2f9edca465e8f0
https://doi.org/10.1016/j.jscai.2023.100942
https://doi.org/10.1016/j.jscai.2023.100942
Autor:
Hans-Peter Goertz, Gurleen Singh Jhuti, Oscar Herrera-Restrepo, EA Wehler, Vincent Antao, Pinar Bilir
Publikováno v:
Cancer Research. 80:P6-13
Objectives: Ado-trastuzumab emtansine (T-DM1) is a HER2-targeted antibody drug conjugate (ADC) indicated for the adjuvant treatment of patients with HER2+ early breast cancer (eBC) who have residual invasive disease after neoadjuvant taxane and trast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4322f140115878488ef7f143784390b0
https://doi.org/10.1158/1538-7445.sabcs19-p6-13-01
https://doi.org/10.1158/1538-7445.sabcs19-p6-13-01
Autor:
S. Kowal, Andrew Quick, James H. Holmes, Narayan Iyer, Kevin N Foster, Eliza Kruger, Jeremiah Sparks, Pinar Bilir, Katie A. Bush, William L. Hickerson, Scott V. Nystrom
Publikováno v:
Advances in Therapy
Introduction When introducing a new intervention into burn care, it is important to consider both clinical and economic impacts, as the financial burden of burns in the USA is significant. This study utilizes a health economic modeling approach to es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc3ba51902c7495b90177b5a7d83684c
http://europepmc.org/articles/PMC6647544
http://europepmc.org/articles/PMC6647544